Martin PawlakDirector Legal, Emerging Therapeutic Areas, Rare Disease & IP at Novo NordiskSpeaker
Agenda Sessions
CASE STUDY Patients and Medicinal Products: Frameworks for Interacting with Patients
, 11:45View Session
